Literature DB >> 17872573

Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Randall E Brand1, Markus M Lerch, Wendy S Rubinstein, John P Neoptolemos, David C Whitcomb, Ralph H Hruban, Teresa A Brentnall, Henry T Lynch, Marcia I Canto.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17872573      PMCID： PMC2000231          DOI： 10.1136/gut.2006.108456

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  83 in total

1.  Familial risk of pancreatic cancer.

Authors:  M Schenk; A G Schwartz; E O'Neal; M Kinnard; J K Greenson; J P Fryzek; G S Ying; D H Garabrant
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 13.506

2.  High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Authors:  A Borg; T Sandberg; K Nilsson; O Johannsson; M Klinker; A Måsbäck; J Westerdahl; H Olsson; C Ingvar
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

3.  Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study.

Authors:  Patrick Maisonneuve; Stacey C FitzSimmons; Joseph P Neglia; Preston W Campbell; Albert B Lowenfels
Journal:  J Natl Cancer Inst       Date:  2003-03-05       Impact factor: 13.506

4.  Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.

Authors:  Fergus J Couch; Michele R Johnson; Kari Rabe; Lisa Boardman; Robert McWilliams; Mariza de Andrade; Gloria Petersen
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

5.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

6.  Pancreatitis and the risk of pancreatic cancer.

Authors:  E Fernandez; C La Vecchia; M Porta; E Negri; B d'Avanzo; P Boyle
Journal:  Pancreas       Date:  1995-08       Impact factor: 3.327

7.  Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population.

Authors:  Jee-Eun Kim; Kyu Taek Lee; Jong Kyun Lee; Seung Woon Paik; Jong Chul Rhee; Kyoo Wan Choi
Journal:  J Gastroenterol Hepatol       Date:  2004-02       Impact factor: 4.029

8.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

9.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors:  J Everhart; D Wright
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

Review 10.  Genetic alterations in pancreatic carcinoma.

Authors:  Gunter Schneider; Roland M Schmid
Journal:  Mol Cancer       Date:  2003-01-22       Impact factor: 27.401
View more
  104 in total

Review 1.  Familial pancreatic cancer--current knowledge.

Authors:  Detlef K Bartsch; Thomas M Gress; Peter Langer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

2.  [Chronic pancreatitis as a risk factor for the development of pancreatic cancer--diagnostic challenges].

Authors:  Tilman Pickartz; Julia Mayerle; Matthias Kraft; Matthias Evert; Katja Evert; Jens-Peter Kühn; Claus-Dieter Heidecke; Markus M Lerch
Journal:  Med Klin (Munich)       Date:  2010-04

Review 3.  Review of screening for pancreatic cancer in high risk individuals.

Authors:  Alina Stoita; Ian D Penman; David B Williams
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

4.  Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated.

Authors:  Femme Harinck; Irma Kluijt; Saskia E van Mil; Quinten Waisfisz; Theo A M van Os; Cora M Aalfs; Anja Wagner; Maran Olderode-Berends; Rolf H Sijmons; Ernst J Kuipers; Jan-Werner Poley; Paul Fockens; Marco J Bruno
Journal:  Eur J Hum Genet       Date:  2011-12-14       Impact factor: 4.246

Review 5.  Chemoprevention strategies for pancreatic cancer.

Authors:  Silvia D Stan; Shivendra V Singh; Randall E Brand
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-04       Impact factor: 46.802

Review 6.  Hereditary pancreatic cancer.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

Review 7.  Pancreatic Cancer Surveillance: Who, When, and How.

Authors:  Beth Dudley; Randall E Brand
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 8.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 9.  Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2012-08-10       Impact factor: 7.851

Review 10.  [Hereditary pancreatic cancer].

Authors:  N Habbe; P Langer; D K Bartsch
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.